These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33862010)

  • 1. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
    Labrosse R; Barmettler S; Derfalvi B; Blincoe A; Cros G; Lacombe-Barrios J; Barsalou J; Yang N; Alrumayyan N; Sinclair J; Ong MS; Camargo CA; Walter J; Haddad E
    J Allergy Clin Immunol; 2021 Aug; 148(2):523-532.e8. PubMed ID: 33862010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.
    Khojah AM; Miller ML; Klein-Gitelman MS; Curran ML; Hans V; Pachman LM; Fuleihan RL
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):61. PubMed ID: 31462263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.
    Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
    J Autoimmun; 2015 Feb; 57():60-5. PubMed ID: 25556904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
    Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
    J Autoimmun; 2015 Feb; 57():24-9. PubMed ID: 25586449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections.
    Langer-Gould A; Li BH; Smith JB; Xu S
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200211. PubMed ID: 38507657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD.
    Mears V; Jakubecz C; Seeco C; Woodson S; Serra A; Abboud H
    J Neuroimmunol; 2023 Apr; 377():578066. PubMed ID: 36917920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
    Barmettler S; Ong MS; Farmer JR; Choi H; Walter J
    JAMA Netw Open; 2018 Nov; 1(7):e184169. PubMed ID: 30646343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
    Parmentier C; Delbet JD; Decramer S; Boyer O; Hogan J; Ulinski T
    Pediatr Nephrol; 2020 Mar; 35(3):455-462. PubMed ID: 31705306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
    McAtee CL; Lubega J; Underbrink K; Curry K; Msaouel P; Barrow M; Muscal E; Lotze T; Srivaths P; Forbes LR; Allen C; Bernhardt MB
    JAMA Netw Open; 2021 Feb; 4(2):e2036321. PubMed ID: 33533931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.
    Inoki Y; Kamei K; Nishi K; Sato M; Ogura M; Ishiguro A
    Pediatr Nephrol; 2022 May; 37(5):1057-1066. PubMed ID: 34606002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease.
    Tieu J; Smith RM; Gopaluni S; Kumararatne DS; McClure M; Manson A; Houghton S; Jayne DRW
    Front Immunol; 2021; 12():671503. PubMed ID: 34054846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT.
    Luterbacher F; Bernard F; Baleydier F; Ranza E; Jandus P; Blanchard-Rohner G
    Front Immunol; 2021; 12():773853. PubMed ID: 35003091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia.
    Kridin K; Ahmed AR
    Autoimmun Rev; 2020 Mar; 19(3):102466. PubMed ID: 31917267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab.
    Besada E
    BMC Musculoskelet Disord; 2016 Jan; 17():6. PubMed ID: 26738559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience.
    Evangelatos G; Fragoulis GE; Klavdianou K; Moschopoulou M; Vassilopoulos D; Iliopoulos A
    Rheumatology (Oxford); 2021 May; 60(5):2375-2382. PubMed ID: 33175958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study.
    Podestà MA; Mescia F; Ricchiuto A; Smith R; Tedesco M; Cassia MA; Holle J; Sinico RA; Bruchfeld A; Gunnarsson I; Ohlsson S; Baslund B; Hruskova Z; Tesar V; Sabiu G; Gallieni M; Cid MC; Vaglio A; Harper L; Cozzolino M; Scolari F; Jayne D; Alberici F
    Rheumatology (Oxford); 2023 Aug; 62(8):2850-2854. PubMed ID: 36562566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience.
    Kim SH; Park NY; Kim KH; Hyun JW; Kim HJ
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35853752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.
    Casulo C; Maragulia J; Zelenetz AD
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):106-11. PubMed ID: 23276889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study.
    Wade SD; Kyttaris VC
    Rheumatol Int; 2021 Jun; 41(6):1115-1124. PubMed ID: 33811499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogammaglobulinemia and bacterial infections following pediatric post-transplant lymphoproliferative disorder in the rituximab era.
    Chiou FK; Beath SV; Patel M; Gupte GL
    Pediatr Transplant; 2019 Sep; 23(6):e13519. PubMed ID: 31209964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.